Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 52,250 | 35,465 | 63,921 | 283,068 | 116,772 |
| Gross Profit | 52,250 | 35,465 | 63,921 | 283,068 | 116,772 |
| Operating Expenses | 151,646 | 145,056 | 124,027 | 103,367 | 80,307 |
| Operating Income | -99,396 | -109,591 | -60,106 | 179,701 | 36,465 |
| Interest Expense | 0 | 0 | 0 | 91 | 329 |
| Other Income | 796 | 1,183 | 1,458 | 746 | 1,154 |
| Pre-tax Income | -98,600 | -108,408 | -58,648 | 180,356 | 37,290 |
| Net Income Continuous | -98,600 | -108,408 | -58,648 | 180,356 | 37,290 |
| Net Income | $-98,600 | $-108,408 | $-58,648 | $180,356 | $37,290 |
| EPS Basic Total Ops | -1.91 | -2.13 | -1.16 | 3.62 | 0.84 |
| EPS Basic Continuous Ops | -1.91 | -2.13 | -1.16 | 3.62 | 0.84 |
| EPS Diluted Total Ops | -1.91 | -2.13 | -1.16 | 3.55 | 0.81 |
| EPS Diluted Continuous Ops | -1.91 | -2.13 | -1.16 | 3.55 | 0.81 |
| EPS Diluted Before Non-Recurring Items | -1.91 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-88,536 | $-97,847 | $-49,338 | $186,893 | $42,018 |